- Investing Ideas
- /
- Hong Kong Healthcare Potentially Undervalued Companies
Hong Kong Healthcare Potentially Undervalued Companies
Results
71
Companies with a Value score of at least 3, ordered by Value score
71 companies
Aidigong Maternal & Child Health
Market Cap: HK$251.8m
An investment holding company, provides postpartum care and healthcare services in the People’s Republic of China.
286
HK$1.31
7D
0%
1Y
-46.3%
AK Medical Holdings
Market Cap: HK$6.4b
An investment holding company, designs, develops, produces, and markets orthopedic joint implants and related products in China and internationally.
1789
HK$5.74
7D
-1.4%
1Y
11.9%
MediNet Group
Market Cap: HK$13.7m
An investment holding company, provides medical and dental solutions to corporates, insurance companies, and individuals in Hong Kong and the People’s Republic of China.
8161
HK$0.33
7D
-1.5%
1Y
-16.5%
AK Medical Holdings
Market Cap: HK$6.4b
An investment holding company, designs, develops, produces, and markets orthopedic joint implants and related products in China and internationally.
1789
HK$5.74
7D
-1.4%
1Y
11.9%
AK Medical Holdings
Market Cap: HK$6.4b
An investment holding company, designs, develops, produces, and markets orthopedic joint implants and related products in China and internationally.
1789
HK$5.74
7D
-1.4%
1Y
11.9%
Xikang Cloud Hospital Holdings
Market Cap: HK$698.8m
An investment holding company, primarily provides cloud hospital platform services in the People's Republic of China.
9686
HK$0.83
7D
20.3%
1Y
-6.7%
Shanghai Pharmaceuticals Holding
Market Cap: HK$61.5b
Shanghai Pharmaceuticals Holding Co., Ltd.
2607
HK$10.80
7D
2.5%
1Y
0.9%
Jinxin Fertility Group
Market Cap: HK$8.3b
An investment holding company, provides assisted reproductive services (ARS) in China and the United States.
1951
HK$3.01
7D
-7.1%
1Y
30.9%
Guangzhou Baiyunshan Pharmaceutical Holdings
Market Cap: HK$42.9b
Researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People’s Republic of China and internationally.
874
HK$16.52
7D
-0.2%
1Y
-16.9%
Yestar Healthcare Holdings
Market Cap: HK$193.5m
An investment holding company, manufactures and sells medical imaging products in Mainland China.
2393
HK$0.083
7D
16.9%
1Y
97.6%
Guangzhou Baiyunshan Pharmaceutical Holdings
Market Cap: HK$42.9b
Researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People’s Republic of China and internationally.
874
HK$16.52
7D
-0.2%
1Y
-16.9%
EuroEyes International Eye Clinic
Market Cap: HK$898.0m
Provides vision correction services for the treatment of myopia, presbyopia, and cataract in Germany, Denmark, the United Kingdom, and the People’s Republic of China.
1846
HK$2.80
7D
-7.0%
1Y
-38.6%
Rici Healthcare Holdings
Market Cap: HK$1.8b
An investment holding company, operates general hospitals, medical examination centers, medical laboratories, and clinics in the People’s Republic of China.
1526
HK$1.13
7D
3.7%
1Y
2.7%
Shanghai Pioneer Holding
Market Cap: HK$2.6b
An investment holding company, markets, promotes, and sells pharmaceutical products and medical devices primarily in the People’s Republic of China.
1345
HK$2.23
7D
-0.9%
1Y
16.8%
Hygeia Healthcare Holdings
Market Cap: HK$8.4b
Offers oncology healthcare services in the People's Republic of China.
6078
HK$13.64
7D
0.9%
1Y
-53.0%
Gushengtang Holdings
Market Cap: HK$7.0b
An investment holding company, provides healthcare services in the People’s Republic of China.
2273
HK$29.35
7D
-1.3%
1Y
-29.4%
Hygeia Healthcare Holdings
Market Cap: HK$8.4b
Offers oncology healthcare services in the People's Republic of China.
6078
HK$13.64
7D
0.9%
1Y
-53.0%
Yunkang Group
Market Cap: HK$1.9b
Operates as a medical operation service provider in the People's Republic of China.
2325
HK$3.20
7D
-4.5%
1Y
-71.1%
Sisram Medical
Market Cap: HK$2.0b
Engages in the research, design, development, manufacture, and sales of medical aesthetics and dental equipment, home use devices, injectables, and cosmeceuticals products in the Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa.
1696
HK$4.23
7D
-1.9%
1Y
23.3%
Town Health International Medical Group
Market Cap: HK$1.7b
An investment holding company, provides healthcare and related services in the People’s Republic of China and Hong Kong.
3886
HK$0.26
7D
7.6%
1Y
-12.1%
Gushengtang Holdings
Market Cap: HK$7.0b
An investment holding company, provides healthcare services in the People’s Republic of China.
2273
HK$29.35
7D
-1.3%
1Y
-29.4%
Angelalign Technology
Market Cap: HK$7.9b
An investment holding company, researches and develops, designs, manufactures, and markets clear aligner treatment solutions in the People’s Republic of China.
6699
HK$46.65
7D
-1.2%
1Y
-39.4%
MedSci Healthcare Holdings
Market Cap: HK$546.1m
Medsci Healthcare Holdings Limited operates as an online professional physician platform service provider in the People’s Republic of China and the United States.
2415
HK$1.01
7D
6.3%
1Y
-60.7%
Grand Brilliance Group Holdings
Market Cap: HK$80.0m
An investment holding company, engages in supplying of medical devices in Hong Kong.
8372
HK$0.10
7D
-1.0%
1Y
-2.0%
Sinohealth Holdings
Market Cap: HK$1.3b
Provides healthcare insight solutions for sales and marketing needs of medical product manufacturer clients in Mainland China and internationally.
2361
HK$3.25
7D
2.5%
1Y
-39.8%
Hygeia Healthcare Holdings
Market Cap: HK$8.4b
Offers oncology healthcare services in the People's Republic of China.
6078
HK$13.64
7D
0.9%
1Y
-53.0%
Gushengtang Holdings
Market Cap: HK$7.0b
An investment holding company, provides healthcare services in the People’s Republic of China.
2273
HK$29.35
7D
-1.3%
1Y
-29.4%
C-MER Medical Holdings
Market Cap: HK$1.7b
An investment holding company, provides ophthalmic services under the C-MER Dennis Lam brand name in Hong Kong and Mainland China.
3309
HK$1.43
7D
2.1%
1Y
-50.7%
Mega Genomics
Market Cap: HK$1.6b
A genetic testing platform company, provides consumer genetic testing and cancer screening services in China.
6667
HK$7.20
7D
0%
1Y
-20.2%
MicroPort NeuroScientific
Market Cap: HK$5.5b
Engages in the research and development, production, and sale of neuro-interventional medical devices in the People’s Republic of China and internationally.
2172
HK$9.60
7D
-1.6%
1Y
13.3%
Angelalign Technology
Market Cap: HK$7.9b
An investment holding company, researches and develops, designs, manufactures, and markets clear aligner treatment solutions in the People’s Republic of China.
6699
HK$46.65
7D
-1.2%
1Y
-39.4%
New Horizon Health
Market Cap: HK$6.3b
An investment holding company, engages in the research and development of screening products for colorectal, cervical, and other types of cancer in the People’s Republic of China.
6606
HK$14.14
7D
0%
1Y
-52.3%
MicroPort NeuroScientific
Market Cap: HK$5.5b
Engages in the research and development, production, and sale of neuro-interventional medical devices in the People’s Republic of China and internationally.
2172
HK$9.60
7D
-1.6%
1Y
13.3%
Angelalign Technology
Market Cap: HK$7.9b
An investment holding company, researches and develops, designs, manufactures, and markets clear aligner treatment solutions in the People’s Republic of China.
6699
HK$46.65
7D
-1.2%
1Y
-39.4%
MicroPort NeuroScientific
Market Cap: HK$5.5b
Engages in the research and development, production, and sale of neuro-interventional medical devices in the People’s Republic of China and internationally.
2172
HK$9.60
7D
-1.6%
1Y
13.3%